Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Olgiati

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|February 2, 2026
The rationale for a European Defence Health AgencyStefano Olgiati, Nima Heidari, Alessandro Danovi
Cureus|April 9, 2024
A Gender-Bias-Mitigated, Data-Driven Precision Medicine System to Assist in the Selection of Biological Treatments of Grade 3 and 4 Knee Osteoarthritis: Development and Preliminary Validation of precisionKNEENima Heidari, Stefano Olgiati, Davide Meloni, et al.
Cureus|January 12, 2024
A Quantum-Enhanced Precision Medicine Application to Support Data-Driven Clinical Decisions for the Personalized Treatment of Advanced Knee Osteoarthritis: The Development and Preliminary Validation of precisionKNEE_QNNNima Heidari, Stefano Olgiati, Davide Meloni, et al.
Stem Cells International|August 25, 2020
Patient-Centered Outcomes of Microfragmented Adipose Tissue Treatments of Knee Osteoarthritis: An Observational, Intention-to-Treat Study at Twelve MonthsNima Heidari, Ali Noorani, Mark Slevin, et al.
Journal of Clinical Medicine|February 25, 2022
Comparison of the Effect of MFAT and MFAT + PRP on Treatment of Hip Osteoarthritis: An Observational, Intention-to-Treat Study at One YearNima Heidari, Mark Slevin, Yasmin Zeinolabediny, et al.
Stem Cells International|July 2, 2021
Microfragmented Adipose Tissue Injection (MFAT) May Be a Solution to the Rationing of Total Knee Replacement: A Prospective, Gender-Bias Mitigated, Reproducible Analysis at Two YearsNima Heidari, Tiffanie-Marie Borg, Stefano Olgiati, et al.
Stem Cells International|March 17, 2021
Gender-Specific Response in Pain and Function to Biologic Treatment of Knee Osteoarthritis: A Gender-Bias-Mitigated, Observational, Intention-to-Treat Study at Two YearsTiffanie-Marie Borg, Nima Heidari, Ali Noorani, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|February 2, 2026
The rationale for a European Defence Health AgencyStefano Olgiati, Nima Heidari, Alessandro Danovi
Cureus|April 9, 2024
A Gender-Bias-Mitigated, Data-Driven Precision Medicine System to Assist in the Selection of Biological Treatments of Grade 3 and 4 Knee Osteoarthritis: Development and Preliminary Validation of precisionKNEENima Heidari, Stefano Olgiati, Davide Meloni, et al.
Cureus|January 12, 2024
A Quantum-Enhanced Precision Medicine Application to Support Data-Driven Clinical Decisions for the Personalized Treatment of Advanced Knee Osteoarthritis: The Development and Preliminary Validation of precisionKNEE_QNNNima Heidari, Stefano Olgiati, Davide Meloni, et al.
Stem Cells International|August 25, 2020
Patient-Centered Outcomes of Microfragmented Adipose Tissue Treatments of Knee Osteoarthritis: An Observational, Intention-to-Treat Study at Twelve MonthsNima Heidari, Ali Noorani, Mark Slevin, et al.
Journal of Clinical Medicine|February 25, 2022
Comparison of the Effect of MFAT and MFAT + PRP on Treatment of Hip Osteoarthritis: An Observational, Intention-to-Treat Study at One YearNima Heidari, Mark Slevin, Yasmin Zeinolabediny, et al.
Stem Cells International|July 2, 2021
Microfragmented Adipose Tissue Injection (MFAT) May Be a Solution to the Rationing of Total Knee Replacement: A Prospective, Gender-Bias Mitigated, Reproducible Analysis at Two YearsNima Heidari, Tiffanie-Marie Borg, Stefano Olgiati, et al.
Stem Cells International|March 17, 2021
Gender-Specific Response in Pain and Function to Biologic Treatment of Knee Osteoarthritis: A Gender-Bias-Mitigated, Observational, Intention-to-Treat Study at Two YearsTiffanie-Marie Borg, Nima Heidari, Ali Noorani, et al.
Pageof 1